Sera Prognostics SERA
NASDAQ SERA
$2.07 +0.08 (+4.02%)
As of: Aug 20, 2026 · 3:59 PM EDT

Sera Prognostics (SERA) Operating Margin Growth (3y) (2023 - 2026)

Sera Prognostics (SERA) Operating Margin Growth (3y) (2023 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Operating Margin Growth (3y) (Qtr)
1 Abbott Laboratories 198.70 Bn 193.10 Bn 7.27 Bn -201.00
2 Stryker 125.85 Bn 122.37 Bn 4.50 Bn 586.00
3 Medtronic 118.44 Bn 109.22 Bn 6.41 Bn 78.00
4 Boston Scientific 72.64 Bn 72.10 Bn 3.85 Bn 736.00
5 Edwards Lifesciences 51.94 Bn 47.69 Bn 1.35 Bn 887.00
6 Dexcom 34.48 Bn 32.53 Bn 830.00 Mn 963.00
7 GE HealthCare Technologies 33.60 Bn 31.49 Bn 2.18 Bn 212.00
8 Koninklijke Philips 26.30 Bn 22.98 Bn 4.55 Bn 535.00
9 Steris 23.00 Bn 22.52 Bn 684.20 Mn 244.00
10 Sera Prognostics 103.48 Mn 103.48 Mn -20,000.00 -2.40 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.40 Mn
Mar 31, 2026 -5.55 Mn
Dec 31, 2025 -7.35 Mn
Sep 30, 2025 -4.33 Mn
Jun 30, 2025 -3.98 Mn
Mar 31, 2025 802,632.00
Dec 31, 2024 899,519.00
Sep 30, 2024 1.05 Mn
Jun 30, 2024 -164,917.00
Dec 31, 2023 5.77 Mn
Sep 30, 2023 7.34 Mn
Jun 30, 2023 6.20 Mn